Rare variants in ATM and CDK1 variants have been associated with CLL risk in genome-wide analysis [18], whereas evidence for the implication of infrequent events in other genes come from familial studies or single-gene analysis [19,20,21]. This evidence concerns the gene ATM and B-cell chronic lymphocytic leukemia.